Patent · US Active

Compounds and methods for modulating FXR

US8153624B2 · kind B2 · utility

7Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2008
Grant dateApr 10, 2012
Priority date
Expiry dateFeb 13, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.